C. Daniel
- Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3By I. Borget, J. Cadranel, J-P. Pignon, E. Quoix, B. Coudert, V. Westeel, E. Dansin, J. Madelaine, A. Madroszyk, S. Friard, C. Daniel, F. Morin, C. Chouaid and the ERMETIC Collaborative GroupI. BorgetJ. CadranelJ-P. PignonE. QuoixB. CoudertV. WesteelE. DansinJ. MadelaineA. MadroszykS. FriardC. DanielF. Morin
- Comparative cost-effectiveness of three strategies for guiding second-line erlotinib initiation in non small-cell lung cancer: a French prospective multicenter study (ERMETIC Project Part 3)By I. Borget, J. Cadranel, J-P. Pignon, E. Quoix, B. Coudert, V. Westeel, E. Dansin, J. Madelaine, A. Madroszyk, S. Friard, C. Daniel, F. Morin, C. Chouaid and the ERMETIC Collaborative GroupArticle | Published in 2011 in European Respiratory JournalI. BorgetJ. CadranelJ-P. PignonE. QuoixB. CoudertV. WesteelE. DansinJ. MadelaineA. MadroszykS. FriardC. DanielF. Morin
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.